Detailed answers about IMMUNOCLIN LIMITED, including incorporation, status, business activity, and accounts information.
When was IMMUNOCLIN LIMITED founded?
IMMUNOCLIN LIMITED was officially incorporated on 26 January 2000 and is registered under company number 03914021. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is IMMUNOCLIN LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of IMMUNOCLIN LIMITED?
IMMUNOCLIN LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does IMMUNOCLIN LIMITED do?
IMMUNOCLIN LIMITED operates in the following sectors: 21200 - Manufacture of pharmaceutical preparations, 71200 - Technical testing and analysis, 72110 - Research and experimental development on biotechnology. These SIC codes provide insight into the company's business activities and industry focus.
What is IMMUNOCLIN LIMITED's registered address?
The registered office address of IMMUNOCLIN LIMITED is 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH. This is the official address filed with Companies House for legal and statutory correspondence.
Is IMMUNOCLIN LIMITED financially stable?
The most recent accounts for IMMUNOCLIN LIMITED were made up to 28 February 2025, filed as MICRO ENTITY. Next accounts are due by 30 November 2026.